Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667)

ClinicalTrials.gov ID: NCT03407144

Public ClinicalTrials.gov record NCT03407144. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 6:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults With Newly Diagnosed Classical Hodgkin Lymphoma With Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will examine the safety and efficacy of pembrolizumab (MK-3475) in combination with chemotherapy in children and young adults with newly diagnosed classical Hodgkin Lymphoma (cHL) who are slow early responders (SERs) to frontline chemotherapy.

Study identification

NCT ID
NCT03407144
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
340 participants

Conditions and interventions

Eligibility (public fields only)

Age range
3 Years to 25 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 9, 2018 (Actual)
Primary completion
Feb 12, 2027 (Estimated)
Completion
Feb 12, 2027 (Estimated)
Last update posted
Oct 2, 2026

2018 – 2027

United States locations

U.S. sites
47
U.S. states
26
U.S. cities
44
Facility City State ZIP Site status
Children's Hospital of Alabama ( Site 0023) Birmingham Alabama 35233 —
Phoenix Childrens Hospital ( Site 0034) Phoenix Arizona 85016 —
Arkansas Children's Hospital ( Site 0046) Little Rock Arkansas 72202 —
Kaiser - Orange County ( Site 0084) Anaheim California 92806 —
Kaiser Permanente ( Site 0082) Downey California 90242 —
Kaiser - Fontana ( Site 0083) Fontana California 92335 —
MemorialCare Health System - Long Beach Medical Center-Cherese Mari Laulhere Children's Village ( Si Long Beach California 90806 —
Kaiser Permanente Downey Medical Center ( Site 0024) Los Angeles California 90027 —
Kaiser Permanente - Oakland ( Site 0047) Oakland California 94611 —
Kaiser Permanente - Roseville ( Site 0080) Roseville California 95661 —
Kaiser Permanente - Santa Clara ( Site 0079) Santa Clara California 95051 —
Children's Hospital - Colorado ( Site 0028) Aurora Colorado 80045 —
Connecticut Children's Medical Center ( Site 0045) Hartford Connecticut 06106 —
Yale Cancer Center ( Site 0061) New Haven Connecticut 06510 —
Children's National Medical Center ( Site 0090) Washington D.C. District of Columbia 20010 —
University of Florida ( Site 0051) Gainesville Florida 32610 —
Memorial Regional Hospital/Joe DiMaggio Children's Hospital ( Site 0048) Hollywood Florida 33021 —
Arnold Palmer Hospital ( Site 0065) Orlando Florida 32806 —
Children's Healthcare of Atlanta at Egleston ( Site 0033) Atlanta Georgia 30322 —
University of Chicago ( Site 0066) Chicago Illinois 60637 —
Riley Hospital for Children ( Site 0091) Indianapolis Indiana 46202 —
University of Kentucky Markey Cancer Center ( Site 0057) Lexington Kentucky 40536-0293 —
University of Louisville-Norton Children's Hospital ( Site 0059) Louisville Kentucky 40202 —
Johns Hopkins University ( Site 0025) Baltimore Maryland 21287 —
Children's Hospital of Michigan ( Site 0056) Detroit Michigan 48201 —
Karmanos Cancer Institute ( Site 0002) Detroit Michigan 48201 —
Children's Hospitals and Clinics of Minnesota ( Site 0036) Minneapolis Minnesota 55404 —
St. Louis Children's Hospital ( Site 0038) St Louis Missouri 63110 —
Alliance for Childhood Diseases ( Site 0064) Las Vegas Nevada 89135 —
Hackensack University Medical Center ( Site 0026) Hackensack New Jersey 07601 —
Rutgers Cancer Institute of New Jersey ( Site 0027) New Brunswick New Jersey 08901 —
Roswell Park Cancer Institute ( Site 0040) Buffalo New York 14263 —
Cohen Children's Medical Center of New York ( Site 0052) New Hyde Park New York 11040 —
Columbia University/Herbert Irving Cancer Center ( Site 0063) New York New York 10032 —
Memorial Sloan Kettering Cancer Center ( Site 0060) New York New York 10065 —
Weill Cornell Medicine ( Site 0032) New York New York 10065 —
UNC Lineberger Comprehensive Cancer ( Site 0044) Chapel Hill North Carolina 27514 —
Cincinnati Children's Hospital Medical Center ( Site 0035) Cincinnati Ohio 45229 —
Nationwide Children's Hospital ( Site 0037) Columbus Ohio 43205-2696 —
St. Francis Hospital Cancer Center ( Site 0001) Greenville South Carolina 29607 —
Vanderbilt University Medical Center-Ingram Cancer Center ( Site 0054) Nashville Tennessee 37232 —
Dell Children's Medical Center Of Central Texas ( Site 0058) Austin Texas 78723 —
Children's Medical Center ( Site 0030) Dallas Texas 75235 —
Texas Children's Hospital ( Site 0042) Houston Texas 77030 —
Methodist HealthCare System of San Antonio Clinical Trials Office, Texas Transplant Institute ( Site San Antonio Texas 78229 —
Inova Fairfax Hospital ( Site 0031) Falls Church Virginia 22042 —
Seattle Childrens Hospital ( Site 0022) Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03407144, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 2, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03407144 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →